Viyash Scientific Limited's board approved its Q1 consolidated results. The company will also allot shares to employees and incorporate a subsidiary in Vietnam. Additionally, Viyash will invest up to ₹400 crore in its wholly-owned subsidiary, Alivira Animal Health, through a rights issue to strengthen its capital structure.